A glimpse of our AutoOCT™ web-based platform

After nearly 2 years in stealth mode with just a placeholder website, the whole team worked really hard to gain the trust of our investors (StartCodon, Cambridge Enterprise, KQ Labs and Ewan Kirk) and funders (BHF and InnovateUK) allowing us further development of our solution. This new website now unveils some of the work we have been up to, more context and news will come over the coming months, so stay tuned.

In the meantime, if you have an interest to know more in partnering or investing, please do not hesitate to reach out on info@octiocor.com.

We are thrilled to announce that Octiocor Ltd has been awarded a highly competitive grant from Innovate UK under its Advancing Precision Medicine initiative. This prestigious recognition not only highlights the groundbreaking work the company is doing at the intersection of artificial intelligence and cardiovascular healthcare but also enables the acceleration of the research & development, regulatory progress, and commercialisation of the AutoOCT™ AI image analysis software for intracoronary artery imaging.

A Leap Forward in Cardiovascular Diagnostics Cardiovascular disease remains the leading cause of mortality globally. Timely and accurate diagnosis is critical to improving patient outcomes. Our proprietary AI software harnesses advanced machine learning and computer vision to analyse intracoronary images with exceptional speed and precision, supporting clinicians in detecting and assessing arterial plaque, stenosis, and other high-risk conditions more effectively. The Innovate UK grant will directly support the next phase of our research and development efforts, which includes:

-Enhancing algorithm accuracy through expanded datasets and continual learning models.

-Scaling clinical validation in collaboration with leading hospitals and research institutions.

-Building robust regulatory and commercial frameworks to bring our solution to market in the UK and internationally.

A Vision for Precision Medicine This funding reflects our commitment to shaping the future of precision medicine where diagnostics are more tailored, intervention is timely, and treatment is data-driven. Our AI solution is designed to integrate into existing catheter lab workflows, where it will deliver real-time analysis that empowers cardiologists to make faster, more informed decisions. “Innovate UK’s support is a game-changer,” said Prof Martin Bennett, CMO and co-founder of Octiocor. “It not only validates the impact of our technology but also propels us closer to our goal of transforming intracoronary diagnostics and improving patient care worldwide.”

Driving Innovation Through Collaboration We extend our thanks to Innovate UK for this opportunity and look forward to deepening our collaborations with NHS partners, academic researchers, and medtech industry leaders. Together, we’re advancing the frontier of cardiovascular AI and bringing cutting-edge technology from the lab to the clinic.